Exane Derivatives’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	$338	Sell	32 -7,495	-100%	-$79.2K	﹤0.01%	617
2022 Q1	$122K	Sell	7,527 -3,819	-34%	-$62.1K	0.03%	438
2021 Q4	$157K	Buy	11,346 +4,727	+71%	+$65.5K	0.04%	379
2021 Q3	$95.1K	Buy	+6,619	New	+$95.1K	0.02%	517